Blue Horizon Enterprise Ltd, 10% Owner at Stoke Therapeutics, Inc. (STOK), sold 2,000,000 shares at $11.50 ($23.0M) on 2024-12-23, disclosed to the SEC on 2024-12-27.
Open-market sale of $23.0M STOK by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| Filing → |